Market Overview:

MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Active Implantable Medical Device Market, The Global Active Implantable Medical Device Market size was valued at around USD 29 billion in 2024 and is projected to reach USD 45 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.8% during the forecast period, i.e. 2025-30. Various factors are attributed to the growth of the market like growth in automobile production, growing focus on lightweight & sustainable materials, rising demand for luxury & customized interiors, increasing focus on safety standards, and the adoption of Advanced Driver Assistance Systems (ADAS). The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Active Implantable Medical Device Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.

Industry Outlook & Forecasts:

• Forecast Period: 2025-2030
• Market Size in 2024: USD 29 billion
• CAGR (2025-2030): 7.8%

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/active-implantable-medical-device-market.html

Global Active Implantable Medical Device Market Segmentation Breakdown:

• By Product Type
  • Implantable Cardioverter Defibrillators - Market Size & Forecast 2020-2030F, USD Million
    • Transvenous implantable Cardioverter Defibrillators – Market Size & Forecast 2020-2030F, USD Million
      • Biventricular Implantable Cardioverter Defibrillators – Market Size & Forecast 2020-2030F, USD Million
      • Dual-Chamber Implantable Cardioverter Defibrillators –Market Size & Forecast 2020-2030F, USD Million
      • Single-Chamber Implantable Cardioverter Defibrillators – Market Size & Forecast 2020-2030F, USD Million
    • Subcutaneous implantable Cardioverter Defibrillators – Market Size & Forecast 2020-2030F, USD Million
  • Implantable Cardiac Pacemakers - Market Size & Forecast 2020-2030F, USD Million
  • Ventricular Assist Devices - Market Size & Forecast 2020-2030F, USD Million
  • Implantable Heart Monitors/Insertable Loop Recorders - Market Size & Forecast 2020-2030F, USD Million
  • Neurostimulators - Market Size & Forecast 2020-2030F, USD Million
    • Spinal Cord Stimulators - Market Size & Forecast 2020-2030F, USD Million
    • Deep Brain Stimulators - Market Size & Forecast 2020-2030F, USD Million
    • Sacral Nerve Stimulators - Market Size & Forecast 2020-2030F, USD Million
    • Vagus Nerve Stimulators - Market Size & Forecast 2020-2030F, USD Million
    • Gastric Electrical Stimulators - Market Size & Forecast 2020-2030F, USD Million
  • Implantable Hearing Devices – Market Size & Forecast 2020-2030F, USD Million
    • Active Hearing Implants – Market Size & Forecast 2020-2030F, USD Million
    • Non-active Hearing Implants – Market Size & Forecast 2020-2030F, USD Million
  • Others - Market Size & Forecast 2020-2030F, USD Million

Implantable Cardioverter Defibrillators (ICDs) comprise the most important segment and hold around 40% of the Global Active Implantable Medical Device Market, typically for cardiovascular disorders.

• By End-User
  • Hospital - Market Size & Forecast 2020-2030F, USD Million
  • Ambulatory Surgery Center - Market Size & Forecast 2020-2030F, USD Million
  • Specialty Clinics & Centers - Market Size & Forecast 2020-2030F, USD Million

The hospital sector is the primary consumer of active implantable medical devices. Hospitals dominate the market with about 60% share, due to their advanced medical facilities, expert medical staff, and ability to offer complete care from implantation to post-surgery.

Geographical Growth Insights:

• By Region
  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

North America holds around 35% share of the Global Active Implantable Medical Device Market. The US leads the market due to its advanced healthcare system, widespread use of modern medical technologies, and a robust regulatory framework including FDA endorsements for new devices.

MarkNtel Advisors Highlights Key Market Drivers for Active Implantable Medical Device Market:

Increasing Cases of Cardiovascular Diseases & Neurological Disorders – The major factor pushing the market growth is rising cases of Neurological Disorders and Cardiovascular Diseases globally. As per WHO in 2019, cardiovascular diseases were the primary cause of mortality accounting for around thirty-two percent of all global deaths. Also, as the aging population is growing worldwide, heart diseases will rise such as; arrhythmias, heart failure, and coronary artery diseases. These rising chronic conditions required advanced implantable devices like defibrillators, pacemakers, and left ventricular assist devices.

Moreover, as per the World Health Organization, there were nearly 3 billion people in 2021, suffering from neurological disorders like; Parkinson's disease, epilepsy, and Alzheimer's disease. Also, it is estimated that dementia cases will be up to 152 million people globally by 2050, as per projections by the Global Burden of Disease Study. Most of the time, these illnesses need ongoing care, in which devices like; DBS, cochlear implants, and neurostimulators play a vital role.

A Comprehensive Analysis of Leading Companies in Global Active Implantable Medical Device Market

Abbott Laboratories, Boston Scientific Corporation, Nurotron Biotechnology Co. Ltd., Biotronik Se & Co., Kg, William Demant Holding A/S, Cochlear Limited, Medtronic PLC, Livanova PLC, Med-EL, Sonova Holding AG, Smith & Nephew, Allergan Inc., Stryker Corporation, Straumann AG, Zimmer Biomet, and others

Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/active-implantable-medical-device-market.html

Global Active Implantable Medical Device Industry Recent Development:

• March 2024: Stryker successfully finalized its purchase of SERF SAS, a joint replacement company headquartered in France. This step strengthens their worldwide range and dedication to orthopedic quality, showing excitement about working together with the SERF SAS team in the future.
• February 2024: BIOTRONIK stated that it would provide only its advanced DX models for new single-chamber ICD implants, due to clinical data demonstrating better diagnostics and lower complication risks when compared to standard high-voltage systems.

What are the growth Opportunity driving the Global Active Implantable Medical Device Market?

Growth in Miniaturization of Active Implantable Medical Devices – The global AIMD market is expanding dramatically, which is connected to miniaturization technology. Medical devices are getting smaller, more efficient, and less invasive, improving the results of treatment for patients, and reducing complications at the same time. Devices become more miniaturized to penetrate through small cuts and speed up recovery while reducing pain. For instance, the Micra miniaturized pacemaker is now about the size of a pill and is 93% smaller than the traditional pacemakers. This makes the procedure less invasive and reduces the need for large incisions. The need for frequent replacements has also decreased due to the longer operating times of these devices, which have been made possible by advancements in battery technology. A greater variety of patients including those with smaller body types or more complicated medical conditions can now be better cared for thanks to miniaturization. This is likely to continue as technological advancements improve the performance and longevity of AIMDs.

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Key Advantages of the Report by MarkNtel Advisors:

Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key subsegments, benefiting both market leaders and new entrants.

Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.

Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/active-implantable-medical-device-market.html

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies: 

• The Global Active Implantable Medical Device Market size was valued at around USD 224 billion in 2024and is projected to reach USD 45 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.8% during the forecast period, i.e., 2025-30.
• The Global Active Implantable Medical Device Marketsize was valued at around USD 29 billion in 2024 and is projected to reach USD 45 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.7.8% during the forecast period, i.e. 2025-30.
• The Global Active Implantable Medical Device Market size was valued at around USD 28 billion in 2024and is projected to reach USD 45 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.8% during the forecast period, i.e., 2025-30.  

Media Contact:

Company Name: MarkNtel Advisors

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Email: sales@marknteladvisors.com

Phone: +1 628 895 8081, +91 120 4278433

Website: www.marknteladvisors.com/